Breast Cancer and Herbal Treatment


Breast Cancer and Herbal Treatment


Author-Jyotsna A Saonere (Suryawanshi)
Lecturer in Pharmacy
Govt.Polytechnic, Department of Pharmacy,Amravati (M.S.India)

American Journal of Microbiology and Immunology


All around the world about1.7 millions of females are resulted with breast cancer and arround 522,000 deaths. Which is more common in developed countries than the developing ones. Breast cancer mostly occurs in cells from the lining of milk ducts and the lobules that supply the ducts with milk. Symptoms of Breast cancer includes a lump in the breast, dimpling of skin, change in shape of breast, fluids coming from nipple. Risk factor for development of breast cancer includes age, sex, obesity, lack of physical exercise, alcohol consumption, hormone replacement therapy during menopause, exposure to ionizing radiation, early age at first menstruation, and family history. Breast cancer is the most serious health problem in developed countries, proper diet, exercise and healthy life style can reduces the risk of breast cancer. Surgery and chemotherapy are the treatment for breast cancer, as chemotherapy has many side effects 50% weakness occurs due to cancer and 50% weakness occurs due to chemotherapy, hence herbal drugs or herbal treatment is the best option for breast cancer. Number of herbal drugs are effective in breast cancer In this study detailed study of the herbal drug used in breast cancer is discussed in detail.


Keywords: Hormone,chemotherapy,dimpling,menopause,obesity

Free Full-text PDF


How to cite this article:
Author-Jyotsna A Saonere (Suryawanshi). Breast Cancer and Herbal Treatment. American Journal of Microbiology and Immunology, 2016,1:9. DOI: 10.28933/saonere-ajmi-10-2016


References:

1. www.breastcancer.org
2. “Breast cancer treatment”.NCIRetrieved 29 June 2014
3. Soliman AS, Samadi S, Banerjee M, Chamberlain RM, Aziz Z. Brief Continuing Medical Education (CME) Module Raises Knowledge of Developing Country Physicians. International Electronic Journal Health Education,2006;9: 31-41.
4. Zaveri NT. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Sci,2006; 78: 2073-2080.
5. Winston JC. Health-promoting properties of common herbs. Am J Clin Nutr ,vol. 70; 491-499.
6. Ji HD, Yasumasa I, Takaomi I, Hiroshi T, Hirotake K, et. al. Glycyrrhizin enhances interleukin-12 production in peritoneal macrophages. Immunology,2001; 103: 235-243.
7. Itoh K, Kumagai K. Augmentation of NK activity by several anti-inflammatory agents. Excerpta Med,1983; 641: 460-464.
8. Galeone C, Pelucchi C, Levi F, Negri E, Franceschi S, et al. Onion and garlic use and human cancer. Am J Clin Nutr,2006; 84: 1027-1032.
9. Yang CS, Chhabra SK, Hong JY, Smith TJ. Mechanisms of inhibition of chemical toxicity and carcinogenesis by diallyl sulfide (DAS) and related compounds from garlic. J Nutr,2001; 131: 1041S-5S.
10. Belman S Sakarkar DM, Deshmukh VN. Ethnopharmacological Review of Traditional Medicinal Plants for Anticancer Activity. International Journal of PharmTech Research,2011(3) 298-308.
11. Sakarkar DM, Deshmukh VN. Ethnopharmacological Review of Traditional Medicinal Plants for Anticancer Activity. International Journal of PharmTech Research.2011; 3: 298-308.
12. Nagabhushan M, Bhide SV. Curcumin as an inhibitor of cancer. J Am Coll Nutr;1992 :11;192-198.
13. Nagabhushan M, Bhide SV. Curcumin as an inhibitor of cancer. J Am Coll Nutr;1992 :11;192-198.
14. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003, 23: 363-398.
15. Cao H and Anderson RA. Cinnamon polyphenol extract regulates tristetraprolin and related gene expression in mouse adipocytes, J Agric. Food Chem 2011; 59: 2739–2744.
16. Lin CC, Wu SJ, Chang CH and Ng LT. Antioxidant activity of Cinnamomum cassia, Phytotherapy Research 2003; 17(7) : 726–730.
17. Varalakshmi B,Vijaya anand A, Vijayakumar K and Prasanna R. In vitro antioxidant activity of Cinnamomum zeylanicum linn bark, International Journal of Institutional Pharmacy and Life Sciences 2012; 2(3): 154-166
18. Awale S, Lu J, Kalauni SK, Kurashima Y, Tezuka Y, et al.Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation. Cancer Res.2006, 66: 1751-1757.
19. Tamayo C, Richardson MA, Diamond S, Skoda I. The chemistry and biological activity of herbs used in Flor-Essence herbal tonic and Essiac. Phytother Res.2000, 14: 1-14.
20. Miyamoto K, Nomura M, Sasakura M, Matsui E, Koshiura R, et al. Antitumor activity of oenothein B, a unique macrocyclic ellagitannin. Jpn J Cancer Res1993, 84: 99-103.
21. Keum YS, Park KK, Lee JM, Chun KS, Park JH, et al. Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng. Cancer Lett.2000, 150: 41-48.
22. Wakabayashi C, Hasegawa H, Murata J, Saiki I. In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration. Oncol Res.1997, 9: 411-417.
23. Taik-Koo Y, Soo Yc. A Case-Control Study of Ginseng Intake and Cancer. Int J Epidemiol.1990, 19: 871-876.
24. Thompson LU, Robb P, Serraino M, Cheung F. Mammalian lignan production from various foods. Nutr Cancer.1991; 16: 43-52.
25. Serraino M, Thompson LU. The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesis. Nutr Cancer.1992; 17: 153-159.
26. Lampe JW, Martini MC, Kurzer MS, Adlercreutz H, Slavin JL. Urinary lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder. Am J Clin Nutr. 1994; 60: 122-128.
27. Chen J, Power KA, Mann J, Cheng A, Thompson LU. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Exp Biol Med (Maywood). 2007; 232: 1071-1080.
28. Thompson LU, Chen JM, Li T, Strasser-Weippl K, Goss PE. Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res. 2005; 11: 3828-3835.
29. Rizzi R, Re F, Bianchi A, De Feo V, de Simone F, et al. Mutagenic and antimutagenic activities of Uncaria tomentosa and its extracts. J Ethnopharmacol. 1993 38: 63-77.
30. Riva L, Coradini D, Di Fronzo G, De Feo V, De Tommasi N, et al. The antiproliferative effects of Uncaria tomentosa extracts and fractions on the growth of breast cancer cell line. Anticancer Res. 2001; 21: 2457-2461.
31. Sandoval-Chac?n M, Thompson JH, Zhang XJ, Liu X, Mannick EE, et al. Antiinflammatory actions of cat’s claw: the role of NF-kappaB. Aliment Pharmacol Ther. 1998; 12: 1279-1289.
32. Yun TK, Choi SY Preventive effect of ginseng intake against various human cancers: a case-control study on 1987 pairs. Cancer Epidemiol Biomarkers Prev. 1995; 4: 401-408.
33. Steffani ND. The anti-carcinogenic effect of Echinacea purpurea and Echinacea pallida on a mammalian breast cancer cell line. 2005
34. Stimpel M, Proksch A, Wagner H, Lohmann-Matthes ML. Macrophage activation and induction of macrophage cytotoxicity by purified polysaccharide fractions from the plant Echinacea purpurea. Infect Immun. 1984; 46: 845-849.
35. Luettig B, Steinm?ller C, Gifford GE, Wagner H, Lohmann-Matthes ML. Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea. J Natl Cancer Inst.1989; 81: 669-675.
36. Shafina Hanim Mohd HabibI; Suzana MakpolI; Noor Aini Abdul HamidI; Srijit DasII; Wan Zurinah Wan NgahI; Yasmin Anum Mohd Yusof Ginger extract (Zingiber officinale) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats Clinics 2008vol.63 no.6 São Paulo
37. Freudenstein J, Dasenbrock C, Nisslein T. Lack of promotion of estrogen-dependent mammary gland tumors in vivo by an isopropanolic Cimicifuga racemosa extract. Cancer Res.2000; 62: 3448-3452.
38. Einbond LS, Shimizu M, Nuntanakom P, Seter C, Cheng R, et al. Actein and a fraction of black cohosh potentiate antiproliferative effects of chemotherapy agents on human breast cancer cells. Planta Med.2006; 72: 1200-1206.
39. Sigstedt SC, Hooten CJ, Callewaert MC, Jenkins AR, Romero AE, et al. Evaluation of aqueous extracts of Taraxacum officinale on growth and invasion of breast and prostate cancer cells. Int J Oncol;2008; 32: 1085-1090.
40. Jean B (1993) Pharmacognosy, phytochemisty, medicinal plants. Lavoisier Publisher, France
41. NerurkarP,RayRBBitteR Melon Antagonist to cancer Pharm Res. 2010 Jun;27(6):1049-53.
42. American Association for Cancer Research. “Bitter melon extract decreased breast cancer cell growth.”ScienceDaily23February2010.
43. Orhan I, Kartal M, Abu-Asaker M, Sezer SF, Yilmazand G, Sener B. Food Chem.2009;114:276–281.
44. Miliauskas G, Venskutonis PR, van Beek TA. Food Chem. 2003;85:231–237
45. Cragg GM, Newman DJ. J. Ethnopharmacol. 2005;100:72–79. [PubMed]
46. Harmon AD, Weiss U, Silverton JV. Tetrahedron Lett. 1979;8:721–724.
47. Chang X, Firestone GL, Bjeldanes LF. Carcinogenesis. 2006;27:541–550. [PubMed]
48. Houghton PJ, Hairong Y. Planta Med. 1987;53:262–264. [PubMed]
49. Lakdawala AD, Shirole MV, Mandrekar SS, Dohadwalla AN. Asia Pac. J. Pharm.1988;3:91–98.
50. Ismail IS, Nagakura Y, Hirasawa Y, Hosoya T, Lazim M, Izwan M, Lajis NH, Shiro M, Morita H. J. Nat. Prod. 2009;72:1879–1883. [PubMed]
51. Takada Y, Aggarwal BB. J. Biol. Chem. 2004;279:4750–4759. [PubMed]
52. . Sedlacek HH, Czech J, Naik R, Kaur G, Worland P, Losiewicz M, Parker B, Carlson B, Smith A. Int. J. Oncol. 1996;9:1143–1168. [PubMed]
53. Carlson BA, Dubay MM, Sausville EA, Brizuela L, Worland P. J. Cancer Res.1996;56:2973–2978. [PubMed]
54. Tan AR, Swain SM. Semin. Oncol. 2002;29:77–85. [PubMed]
55. Jeong J, An JY, Kwon YT, Rhee JG, Lee YJ. J. Cell. Biochem. 2009;106:73–82.[PMC free article] [PubMed]
56. Choi JA, Kim JY, Lee JY, Kang CM, Kwon HJ, Yoo YD, Kim TW, Lee YS, Lee SJ.Int. J. Oncol. 2001;19:837–844
57. . Myung SK, Bae WK, Oh SM, Kim Y, Ju W, Sung J, Lee Y, Ko J, Song JI, Choi HJ.Int. J. Cancer. 2009;124:670–677.
58. 83. Sartippour M, Pietras R, Marquez-Garban DC, Chen HW, Heber D, Henning SM, Sartippour G, Zhang L, Lu M, Weinberg O, Rao JU, Brooks MN. Carcinogenesis.2006;27:2424–2433.
59. 84. Kiitagawa S, Nabekura T, Kamiyama S. J. Pharm. Pharmacol. 2004;56:1001–1005.
60. . Luo T, Wang J, Yancun Y, Hua H, Jing J. Jing, X. Sun, M. Li, J.Y. Zhang. Breast Cancer Res. 2010;12:R8. [PMC free article] [PubMed]
61. 86. Carlson JR, Bauer BA, Vincent A, Limbourg PJ, Wilson T. Mayo Clin. Proc.2007;82:725–732. [PubMed]